Filing Details

Accession Number:
0001022079-20-000175
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-19 16:17:18
Reporting Period:
2020-10-16
Accepted Time:
2020-10-19 16:17:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1142624 H Stephen Rusckowski 500 Plaza Drive
Secaucus NJ 07094
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-16 291,997 $66.51 529,744 No 4 M Direct
Common Stock Disposition 2020-10-16 291,997 $120.00 237,747 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualifed Stock Option (right to buy) Disposition 2020-10-16 291,997 $66.51 291,997 $66.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-02-25 No 4 M Direct
Footnotes
  1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 24, 2020.
  2. The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019.